OXYGEN THERAPY, INC.
CIK 0001685616
Revenue (TTM)
—
Q3 Nov 2017
Net Income (TTM)
−$602.88K
Q3 Nov 2017
EPS Diluted (TTM)
—
Q3 Nov 2017
Gross Margin
—
Q3 Nov 2017
Operating Margin
—
Q3 Nov 2017
Net Margin
—
Q3 Nov 2017
Free Cash Flow (TTM)
—
Q3 Nov 2017
Cash
—
Q3 Nov 2017
Total Debt
—
Q3 Nov 2017
Shares Outstanding
19.94M sh
Q3 Nov 2017